Publicaciones en colaboración con investigadores/as de Universidade de São Paulo (60)

2024

  1. Persistence of IgG4 as a potential serological marker of disease activity in patients with epidermolysis bullosa acquisita treated with rituximab

    Journal of the European Academy of Dermatology and Venereology

2023

  1. Efficacy of Early Optimization of Infliximab Guided by Therapeutic Drug Monitoring during Induction—A Prospective Trial

    Biomedicines, Vol. 11, Núm. 6

2021

  1. Assessment of the intestinal microbiota in adults with erosive esophagitis

    Arquivos de Gastroenterologia, Vol. 58, Núm. 2, pp. 168-174

2020

  1. Esophageal motility patterns are altered in older adult patients

    Revista de Gastroenterologia de Mexico, Vol. 85, Núm. 3, pp. 264-274

  2. Gut microbiota, prebiotics, probiotics, and synbiotics in gastrointestinal and liver diseases: Proceedings of a joint meeting of the brazilian society of hepatology (sbh), brazilian nucleus for the study of helicobacter pylori and microbiota (nbehpm), and brazilian federation of gastroenterology (fbg)

    Arquivos de Gastroenterologia, Vol. 57, Núm. 4, pp. 381-398

  3. Transcutaneous multichannel electrogastrography: Normal parameters in a brazilian population

    Arquivos de Gastroenterologia, Vol. 57, Núm. 4, pp. 428-433

2019

  1. Lactulose Breath Testing Can Be a Positive Predictor Before Weight Gain in Participants with Obesity Submitted to Roux-en-Y Gastric Bypass

    Obesity Surgery, Vol. 29, Núm. 11, pp. 3457-3464

  2. Temporal association between respiratory events and reflux in patients with obstructive sleep apnea and laryngopharyngeal reflux

    Journal of Clinical Sleep Medicine, Vol. 15, Núm. 10, pp. 1397-1402

2017

  1. Prolonged measurement improves the assessment of the barrier function of the esophago-gastric junction by high-resolution manometry

    Neurogastroenterology and Motility, Vol. 29, Núm. 2

2015

  1. Efficacy of levofloxacin, amoxicillin and a proton pump inhibitor in the eradication of Helicobacter pylori in Brazilian patients with peptic ulcers

    Clinics, Vol. 70, Núm. 5, pp. 318-321

  2. Standard Triple Therapy versus Sequential Therapy in Helicobacter pylori Eradication: A Double-Blind, Randomized, and Controlled Trial

    Gastroenterology Research and Practice, Vol. 2015

2014

  1. Acid indigestion: Causes, symptoms and treatment options

    Advances in Medicine and Biology (Nova Science Publishers, Inc.), pp. 116-127

  2. Endoscopic findings in uninvestigated dyspepsia

    BMC Gastroenterology, Vol. 14, Núm. 1

  3. High definition endoscopy and "narrow band imaging" in the diagnosis of gastroesophageal reflux disease

    Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery, Vol. 27, Núm. 1, pp. 59-65

  4. Retracted to Probiotics intake and metabolic syndrome: A proposal [Curr Opin Pharmacol., 9, (2009) 737-743] DOI: 10.1016/j.coph.2009.06.016

    Trends in Food Science and Technology

  5. Salivary transforming growth factor alpha in patients with Sjögren's syndrome and reflux laryngitis

    Brazilian Journal of Otorhinolaryngology, Vol. 80, Núm. 6, pp. 462-469

  6. Ulcer and bleeding complications and their relationship with dyspeptic symptoms in NSAIDs users: A transversal multicenter study

    Scandinavian Journal of Gastroenterology, Vol. 49, Núm. 7, pp. 785-789

2013

  1. Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: A prospective, randomized, double-blind, placebo-controlled study

    BMC Gastroenterology, Vol. 13, Núm. 1

  2. Increase of lower esophageal sphincter pressure after osteopathic intervention on the diaphragm in patients with gastroesophageal reflux

    Diseases of the Esophagus, Vol. 26, Núm. 5, pp. 451-456

  3. Progression of diffuse esophageal spasm to achalasia: Incidence and predictive factors

    Diseases of the Esophagus, Vol. 26, Núm. 5, pp. 470-474